Literature DB >> 19852778

c-KIT positive Gastrointestinal Stromal Tumor presenting with acute bleeding in a patient with neurofibromatosis type 1: a case report.

Esam Aboutaleb1, Manish Kothari, Osama Damrah, Roben Canelo.   

Abstract

BACKGROUND: Gastrointestinal stromal tumours are rare (GIST). However, the incidence of GIST among neurofibromatosis type 1 (NF-1) patients is approximately 3.9-25%. GIST can present clinically in different ways such as abdominal pain, gastrointestinal bleeding and obstruction. CASE REPORT: We present 51 year female patient admitted with Background of neurofibromatosis type 1 admitted with melena. OGD has been done and showed duodenitis with large volume fresh blood in distal duodenum but no obvious bleeding point. Exploratory laparotomy revealed smooth nodular masses on the serosal surface of jejunum. Small bowel resection and side-to-side anastomosis were performed. Histopathoogical examination revealed small bowel gasrointestinal stromal tumour with low risk malignant potential.
CONCLUSION: The incidence of GIST among neurofibromatosis type 1 (NF-1) patients is not uncommon and we should pay attention to gastrointestinal manifestation in such patients.

Entities:  

Year:  2009        PMID: 19852778      PMCID: PMC2776011          DOI: 10.1186/1477-7800-6-17

Source DB:  PubMed          Journal:  Int Semin Surg Oncol        ISSN: 1477-7800


  11 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.

Authors:  Douglas R Stewart; Christopher L Corless; Brian P Rubin; Michael C Heinrich; Ludwine M Messiaen; Lisa J Kessler; Paul J Zhang; David G Brooks
Journal:  J Med Genet       Date:  2007-01       Impact factor: 6.318

3.  Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.

Authors:  Michelle J Frost; Petranel T Ferrao; Timothy P Hughes; Leonie K Ashman
Journal:  Mol Cancer Ther       Date:  2002-10       Impact factor: 6.261

4.  Two von Recklinghausen's disease cases with pheochromocytomas and gastrointestinal stromal tumors (GIST) in combination.

Authors:  Sakiko Teramoto; Tomonori Ota; Akimitsu Maniwa; Takashi Matsui; Naoshi Itaya; Kazumi Aoyagi; Hiroshi Kusanagi; Makoto Narita
Journal:  Int J Urol       Date:  2007-01       Impact factor: 3.369

5.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

6.  Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.

Authors:  Markku Miettinen; John F Fetsch; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-01       Impact factor: 6.394

7.  Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).

Authors:  Yutaka Takazawa; Shinji Sakurai; Yuji Sakuma; Tatsuru Ikeda; Jun Yamaguchi; Yoshio Hashizume; Shigeo Yokoyama; Atsushi Motegi; Masashi Fukayama
Journal:  Am J Surg Pathol       Date:  2005-06       Impact factor: 6.394

8.  Outcome and long term results of surgical resection for gastrointestinal stromal tumors (GIST).

Authors:  I Besana-Ciani; L Boni; G Dionigi; A Benevento; R Dionigi
Journal:  Scand J Surg       Date:  2003       Impact factor: 2.360

9.  Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study.

Authors:  Rhonda K Yantiss; Andrew E Rosenberg; Lisa Sarran; Peter Besmer; Cristina R Antonescu
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

10.  Small bowel gastrointestinal stromal tumours and ampullary cancer in Type 1 neurofibromatosis.

Authors:  Kasim A Behranwala; Duncan Spalding; Andrew Wotherspoon; Cyril Fisher; Jeremy N Thompson
Journal:  World J Surg Oncol       Date:  2004-01-07       Impact factor: 2.754

View more
  3 in total

1.  Clinical outcomes of upper gastrointestinal bleeding in patients with gastric gastrointestinal stromal tumor.

Authors:  Gyu Young Pih; Sung Jin Jeon; Ji Yong Ahn; Hee Kyong Na; Jeong Hoon Lee; Kee Wook Jung; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung; Seon-Ok Kim
Journal:  Surg Endosc       Date:  2019-05-06       Impact factor: 4.584

2.  Clinical outcomes of tumor bleeding in duodenal gastrointestinal stromal tumors: a 20-year single-center experience.

Authors:  Gyu Young Pih; Ji Yong Ahn; Ji Young Choi; Hee Kyong Na; Jeong Hoon Lee; Kee Wook Jung; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung
Journal:  Surg Endosc       Date:  2020-03-13       Impact factor: 4.584

3.  Duodenal wedge resection for large gastrointestinal stromal tumour presenting with life-threatening haemorrhage.

Authors:  Alexander Shaw; John Jeffery; Laura Dias; Sarfraz Nazir
Journal:  Case Rep Gastrointest Med       Date:  2013-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.